Home

Eingestehen Gesundheit Tabelle reuters teva abspielen Hypothese Welken

Teva Pharma to sell more women's health assets for $1.38 billion | Reuters
Teva Pharma to sell more women's health assets for $1.38 billion | Reuters

West Virginia Says J&J, Teva, AbbVie Caused 'Tsunami' Of Opioid Addiction:  Reuters | Markets Insider
West Virginia Says J&J, Teva, AbbVie Caused 'Tsunami' Of Opioid Addiction: Reuters | Markets Insider

Teva Pharmaceutical Industries Ltd
Teva Pharmaceutical Industries Ltd

Teva shares topple on profit warning, uncertain future | Reuters
Teva shares topple on profit warning, uncertain future | Reuters

TEVA Stock Price and Chart — NYSE:TEVA — TradingView
TEVA Stock Price and Chart — NYSE:TEVA — TradingView

Oklahoma Reaches $85 Million Settlement With Teva Pharmaceuticals Ahead of  Trial
Oklahoma Reaches $85 Million Settlement With Teva Pharmaceuticals Ahead of Trial

California judge rules for Israeli Teva in major opioid lawsuit - The  Jerusalem Post
California judge rules for Israeli Teva in major opioid lawsuit - The Jerusalem Post

TEVA stock lower as company eyes up to $3.6 billion to settle opioid claims  - Reuters | Seeking Alpha
TEVA stock lower as company eyes up to $3.6 billion to settle opioid claims - Reuters | Seeking Alpha

Teva gets FDA approval for cancer drug | Reuters
Teva gets FDA approval for cancer drug | Reuters

Teva Pharmaceuticals to Lay Off 14,000 People
Teva Pharmaceuticals to Lay Off 14,000 People

Teva must face government's kickback claims over Copaxone - judge | Reuters
Teva must face government's kickback claims over Copaxone - judge | Reuters

US Supreme Court sides with Teva in drug dispute
US Supreme Court sides with Teva in drug dispute

Teva faces class-action lawsuit over US antitrust probe into price-fixing |  The Times of Israel
Teva faces class-action lawsuit over US antitrust probe into price-fixing | The Times of Israel

Exclusive: CVS to cover migraine drugs from Teva, Lilly; excludes Amgen |  Reuters.com
Exclusive: CVS to cover migraine drugs from Teva, Lilly; excludes Amgen | Reuters.com

Rhode Island takes Teva to trial in multibillion-dollar opioid case - The  Jerusalem Post
Rhode Island takes Teva to trial in multibillion-dollar opioid case - The Jerusalem Post

Teva Pharmaceutical Industries' new CEO Jeremy Levin speaks during a news  conference in Tel Aviv May 9, 2012. Teva Pharmaceutical Industries posted a  40 percent jump in quarterly profit that beat estimates,
Teva Pharmaceutical Industries' new CEO Jeremy Levin speaks during a news conference in Tel Aviv May 9, 2012. Teva Pharmaceutical Industries posted a 40 percent jump in quarterly profit that beat estimates,

Drugmaker Teva may pay as much as $3.6 billion in U.S. opioid settlement |  Reuters
Drugmaker Teva may pay as much as $3.6 billion in U.S. opioid settlement | Reuters

Walgreens, Teva accused of fueling opioid addiction in quest for new  markets | Reuters
Walgreens, Teva accused of fueling opioid addiction in quest for new markets | Reuters

Israeli pharma giant Teva reports shrinking profits amid U.S. opioid  litigation - U.S. News - Haaretz.com
Israeli pharma giant Teva reports shrinking profits amid U.S. opioid litigation - U.S. News - Haaretz.com

Teva CEO exits in ongoing crisis of confidence at drugmaker | Reuters
Teva CEO exits in ongoing crisis of confidence at drugmaker | Reuters

San Francisco To Start Opioid Epidemic Trial Against Teva, Walgreen: Reuters
San Francisco To Start Opioid Epidemic Trial Against Teva, Walgreen: Reuters

Teva Pharmaceutical Industries Ltd | Reuters
Teva Pharmaceutical Industries Ltd | Reuters

Teva's $15B free drug opioid settlement might be a great deal in the long  run: analyst | Fierce Pharma
Teva's $15B free drug opioid settlement might be a great deal in the long run: analyst | Fierce Pharma

Teva, Amgen End Dispute Over Generic Cinacalcet HCl Tablets
Teva, Amgen End Dispute Over Generic Cinacalcet HCl Tablets

Drug-maker Teva fueled opioid addiction in NY, jury finds | Business  Insurance
Drug-maker Teva fueled opioid addiction in NY, jury finds | Business Insurance

Teva's MS drug Copaxone has strong second-quarter sales | Reuters
Teva's MS drug Copaxone has strong second-quarter sales | Reuters

An employee of Teva Pharmaceutical Industries carries a box at the  company's Jerusalem oral solid dosage plant (OSD) December 21, 2011.  Israel-based Teva is the world's leading generic drugmaker. REUTERS/Ronen  Zvulun (JERUSALEM -
An employee of Teva Pharmaceutical Industries carries a box at the company's Jerusalem oral solid dosage plant (OSD) December 21, 2011. Israel-based Teva is the world's leading generic drugmaker. REUTERS/Ronen Zvulun (JERUSALEM -

A Teva Pharmaceutical Industries building is seen in Jerusalem December 14,  2017. REUTERS/Ammar Awad Stock Photo - Alamy
A Teva Pharmaceutical Industries building is seen in Jerusalem December 14, 2017. REUTERS/Ammar Awad Stock Photo - Alamy